| scholarly article | Q13442814 |
| P356 | DOI | 10.1118/1.3464491 |
| P953 | full work available at URL | https://aapm.onlinelibrary.wiley.com/doi/pdf/10.1118/1.3464491 |
| https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1118%2F1.3464491 | ||
| P698 | PubMed publication ID | 20964200 |
| P2093 | author name string | Yongsook C. Lee | |
| Beth A. Goins | |||
| Gary D. Fullerton | |||
| P2860 | cites work | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
| New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 | ||
| Tissue mimicking materials for a multi-imaging modality prostate phantom | Q30651421 | ||
| Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper | Q33377242 | ||
| Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer | Q33427677 | ||
| RECIST revisited: a review of validation studies on tumour assessment | Q34652070 | ||
| Dedicated small animal scanners: a new tool for drug development? | Q34673923 | ||
| From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors | Q34978457 | ||
| Small animal PET. | Q35017890 | ||
| Small animal SPECT and its place in the matrix of molecular imaging technologies. | Q36303677 | ||
| Instrumentation for molecular imaging in preclinical research: Micro-PET and Micro-SPECT. | Q36341230 | ||
| Agarose as a tissue equivalent phantom material for NMR imaging | Q36472586 | ||
| Mucocutaneous and peripheral soft-tissue hemangiomas: MR imaging | Q36483771 | ||
| Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer | Q36645855 | ||
| Radiologic measurements of tumor response to treatment: practical approaches and limitations. | Q37113203 | ||
| Small-animal preclinical nuclear medicine instrumentation and methodology. | Q37132037 | ||
| Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives | Q37232368 | ||
| Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI. | Q37360137 | ||
| Assessing tumor response to therapy | Q37452321 | ||
| Three-dimensional high-frequency ultrasound imaging for longitudinal evaluation of liver metastases in preclinical models | Q40408994 | ||
| Radiologic measurement of tumor size in clinical trials: past, present, and future | Q40729140 | ||
| CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations | Q44200390 | ||
| Imaging of murine liver tumor using microCT with a hepatocyte-selective contrast agent: accuracy is dependent on adequate contrast enhancement | Q44882852 | ||
| Determination of subcutaneous tumor size in athymic (nude) mice | Q46296687 | ||
| Generalized reconstruction of phase contrast MRI: analysis and correction of the effect of gradient field distortions | Q46500308 | ||
| Tumor response assessment is more robust with sequential CT scanning than external caliper measurements | Q46527855 | ||
| Ultrasound for accurate measurement of invasive breast cancer tumor size | Q47338157 | ||
| Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria | Q47378801 | ||
| Head and neck MR imaging in the pediatric patient | Q48337812 | ||
| Magnetic resonance with marked T2-weighted images: improved demonstration of brain lesions, tumor, and edema | Q48441276 | ||
| Effects of static and radiofrequency magnetic field inhomogeneity in ultra-high field magnetic resonance imaging. | Q48664555 | ||
| Analysis and correction of gradient nonlinearity and B0 inhomogeneity related scaling errors in two-dimensional phase contrast flow measurements. | Q51545012 | ||
| MRI geometric distortion: a simple approach to correcting the effects of non-linear gradient fields. | Q52211584 | ||
| Evaluation of gradient inhomogeneity in the optimal design of gradient coils. | Q52419447 | ||
| Soft-tissue masses of the locomotor system: comparison of MR imaging with CT | Q69529416 | ||
| Response assessment in solid tumours: a comparison of WHO, SWOG and RECIST guidelines | Q80811103 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4806-4816 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Medical Physics | Q15764251 |
| P1476 | title | QA procedures for multimodality preclinical tumor drug response testing | |
| P478 | volume | 37 |
| Q41828265 | Construction of a preclinical multimodality phantom using tissue-mimicking materials for quality assurance in tumor size measurement | cites work | P2860 |
Search more.